Potassium Para-Aminobenzoate: Benefits, Uses, and Dosage Guide

Summary of Key Points

Potassium para-aminobenzoate, commonly referred to as Potaba, is a medication used to manage various conditions, including fibrotic diseases and autoimmune disorders. It works by modulating the immune system and reducing inflammation in tissues. Potassium para-aminobenzoate is available in different forms and strengths, and it is crucial to follow your healthcare provider’s instructions closely. Always consult a medical professional before starting or adjusting your dosage. Our telemedicine providers are available to help manage your treatment and answer any questions you may have.

Names of the Medication

US Brand Name: Potaba

The generic name for this medication is potassium para-aminobenzoate. The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer.

Pharmacologic Category

Potassium para-aminobenzoate falls under the following categories:

1. Anti-fibrotic agents
2. Immunomodulators

Potassium Para-Aminobenzoate Dosage

Potassium para-aminobenzoate is prescribed for a variety of conditions, and the dosage may differ depending on the specific diagnosis. Always consult your healthcare provider before making any changes to your dosage. Our telemedicine providers are available to assist with any questions regarding your treatment plan.

Pernicious Anemia

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, as directed by your healthcare provider.

Fibrotic Diseases (Including Peyronie’s Disease)

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Typically 6 months to 1 year, depending on your response to treatment.

Scleroderma

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, as advised by your healthcare provider.

Systemic Lupus Erythematosus

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, depending on your response to treatment.

Rheumatoid Arthritis

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, as directed by your healthcare provider.

Chronic Fatigue Syndrome

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, depending on your response to treatment.

Multiple Sclerosis

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, as advised by your healthcare provider.

Myasthenia Gravis

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, depending on your response to treatment.

Psoriasis

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, as directed by your healthcare provider.

Asthma

Dosage: 12 grams per day, divided into 4 doses.

Frequency: Taken with meals.

Length of Treatment: Long-term, depending on your response to treatment.

Dosage Forms and Strengths

Potassium para-aminobenzoate is available in the following forms:

1. Tablet: 500 mg
2. Powder: 6 grams per packet

How to Take Potassium Para-Aminobenzoate

Potassium para-aminobenzoate should be taken with meals to minimize the risk of stomach upset. It is important to divide the total daily dose into multiple doses throughout the day, as instructed by your healthcare provider. Be sure to drink plenty of water while taking this medication to prevent dehydration. If you miss a dose, take it as soon as you remember, but do not take two doses at once. Always follow your doctor’s instructions carefully, and reach out to one of our telemedicine providers if you have any concerns.

Contraindications for Potassium Para-Aminobenzoate

A contraindication is a specific condition or situation where a medication should not be used because it may cause harm. If you have any of the following conditions, you should avoid taking potassium para-aminobenzoate, or you may require close monitoring by your healthcare provider:

1. Kidney Disease: Potassium para-aminobenzoate can raise potassium levels, which may worsen kidney function or lead to dangerously high potassium levels in patients with kidney disease.
2. Severe Liver Disease: The liver plays a key role in processing medications, and severe liver disease may impair the body’s ability to metabolize potassium para-aminobenzoate, increasing the risk of toxicity.
3. Allergy to PABA (para-aminobenzoic acid): If you are allergic to PABA or its derivatives, taking potassium para-aminobenzoate could trigger an allergic reaction, which could be life-threatening in severe cases.
4. Hyperkalemia (High Potassium Levels): Since potassium para-aminobenzoate contains potassium, it can further elevate potassium levels, potentially leading to dangerous heart rhythm disturbances in patients with hyperkalemia.

Potassium Para-Aminobenzoate Drug Interactions

Potassium para-aminobenzoate may interact with other medications, potentially altering their effects or increasing the risk of side effects. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. The following medications may interact with potassium para-aminobenzoate:

1. Diuretics (Water Pills): Medications such as furosemide (Lasix) or hydrochlorothiazide (Microzide) may increase potassium loss, counteracting the effects of potassium para-aminobenzoate.
2. ACE Inhibitors: Drugs like lisinopril (Zestril) or enalapril (Vasotec) can raise potassium levels, increasing the risk of hyperkalemia when taken with potassium para-aminobenzoate.
3. Potassium-Sparing Diuretics: Medications such as spironolactone (Aldactone) or triamterene (Dyrenium) can also elevate potassium levels, so combining them with potassium para-aminobenzoate could result in dangerously high potassium levels.
4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Drugs like ibuprofen (Advil, Motrin) or naproxen (Aleve) can affect kidney function and potassium levels, increasing the risk of hyperkalemia when taken with potassium para-aminobenzoate.

Potassium para-aminobenzoate in Pregnancy

Is it safe to take Potassium para-aminobenzoate during pregnancy? The safety of Potassium para-aminobenzoate, also known as Potaba, during pregnancy has not been thoroughly studied. Classified as a Category C drug by the FDA, there is currently insufficient research to determine its safety for pregnant women. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of this medication with your healthcare provider. Our telemedicine providers are available to help you make an informed decision.

Potassium para-aminobenzoate while Breastfeeding

Is it safe to take Potassium para-aminobenzoate while breastfeeding? There is limited information regarding the safety of Potassium para-aminobenzoate during breastfeeding. It is not known whether this medication passes into breast milk or if it could have any effects on a nursing infant. If you are breastfeeding, it is essential to consult your healthcare provider before starting this medication. You can schedule a telemedicine appointment with one of our providers to discuss your options.

Estimated Cost of Potassium para-aminobenzoate

The estimated cost of a 30-day supply of Potassium para-aminobenzoate without insurance typically ranges from $100 to $150, depending on the pharmacy and location. By using a GoodRx coupon, the price may be reduced to approximately $80 to $120. Prices can vary, so it’s advisable to check with your pharmacy or use a coupon service like GoodRx to find the best available price.

Possible Alternatives to Potassium para-aminobenzoate

If you are taking Potassium para-aminobenzoate for any of the following conditions, there may be alternative treatments or lifestyle changes that could be beneficial. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are available to discuss these options with you.

1. Pernicious Anemia: Treatment generally involves vitamin B12 supplementation, either through injections or high-dose oral supplements.
2. Fibrotic Diseases: Corticosteroids or immunosuppressive medications may be prescribed to manage fibrosis. Physical therapy can also help improve mobility and function.
3. Scleroderma: Treatment may include medications to manage symptoms, such as immunosuppressants or vasodilators. Physical therapy and skin care routines can also be helpful.
4. Systemic Lupus Erythematosus (SLE): Common treatments include corticosteroids, antimalarial drugs like hydroxychloroquine (Plaquenil), and immunosuppressive medications.
5. Rheumatoid Arthritis: Disease-modifying antirheumatic drugs (DMARDs) like methotrexate, as well as biologics such as adalimumab (Humira), are often used to manage symptoms.
6. Chronic Fatigue Syndrome: Lifestyle changes, such as improving sleep hygiene, pacing activities, and cognitive behavioral therapy (CBT), may help manage symptoms.
7. Multiple Sclerosis: Disease-modifying therapies (DMTs) like interferon beta (Avonex) or glatiramer acetate (Copaxone) are commonly used to slow disease progression.
8. Myasthenia Gravis: Treatment may include acetylcholinesterase inhibitors like pyridostigmine (Mestinon) or immunosuppressive therapies.
9. Psoriasis: Topical treatments, phototherapy, and biologic medications like etanercept (Enbrel) or secukinumab (Cosentyx) may be effective.
10. Asthma: Inhaled corticosteroids, bronchodilators, and lifestyle changes such as avoiding triggers can help manage asthma symptoms.

Recent Updates on Potassium para-aminobenzoate Research

Recent studies on Potassium para-aminobenzoate have focused on its potential use in treating fibrotic conditions, such as Peyronie’s disease and scleroderma. Some research suggests that Potassium para-aminobenzoate may help reduce fibrosis by increasing oxygen uptake in tissues, though more studies are needed to confirm its effectiveness. Researchers are also exploring its role in managing other connective tissue disorders. However, the current evidence remains limited, and further clinical trials are necessary to establish its safety and efficacy for these conditions. If you are interested in learning more about ongoing research, consult with one of our telemedicine providers to discuss whether this medication may be suitable for you.

James Kingsley

Learn More